Edition:
United Kingdom

Aptinyx Inc (APTX.OQ)

APTX.OQ on NASDAQ Stock Exchange Global Select Market

4.04USD
21 Mar 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$4.04
Open
$4.11
Day's High
$4.14
Day's Low
$3.70
Volume
68,513
Avg. Vol
68,751
52-wk High
$32.25
52-wk Low
$3.70

Chart for

About

Aptinyx Inc. is a clinical-stage biopharmaceutical company. The Company discovers and develops therapies for disorders of the brain and nervous system. The Company has a platform for discovering compounds that work through a mechanism, which includes modulation of the N-methyl-D-aspartate (NMDA) receptor to develop pathways... (more)

Overall

No Ratios Available.

Financials

  APTX.OQ Industry Sector
P/E (TTM): -- 29.30 32.54
EPS (TTM): -- -- --
ROI: -- 14.23 13.82
ROE: -- 15.46 15.25

Allergan depression treatment fails studies, shares slip

Allergan Plc said on Wednesday its experimental add-on treatment for depression failed three late-stage studies, casting doubts over its drugs pipeline and sending the Botox-maker's shares down nearly 4 percent after the bell.

06 Mar 2019

UPDATE 2-Allergan depression treatment fails studies, shares slip

March 6 Allergan Plc said on Wednesday its experimental add-on treatment for depression failed three late-stage studies, casting doubts over its drugs pipeline and sending the Botox-maker's shares down nearly 4 percent after the bell.

06 Mar 2019

Earnings vs. Estimates